{"count": 2, "results": [{"_id": "26822064", "pmid": 26822064, "title": "Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review.", "journal": "Psychiatry Res", "authors": ["Bo QJ", "Wang ZM", "Li XB", "Ma X", "Wang CY", "de Leon J"], "date": "2016-03-30T00:00:00Z", "doi": "10.1016/j.psychres.2016.01.031", "meta_date_publication": "2016 Mar 30", "meta_volume": "237", "meta_issue": "", "meta_pages": "257-63", "score": 50060.9, "text_hl": "In one observational study, 91% of @SPECIES_9606 @@@patients@@@ no longer had signs or symptoms of @<m>DISEASE_Galactorrhea</m> @DISEASE_MESH:D005687 @@@galactorrhea@@@. In the RCT, @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@adverse drug reactions@@@ (@DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@ADRs@@@) occurred at similar incidence rates among @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and placebo @SPECIES_9606 @@@patients@@@, except that no significant increases in @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Sleep_Initiation_and_Maintenance_Disorders @DISEASE_MESH:D007319 @@@insomnia@@@ and @DISEASE_Psychomotor_Agitation @DISEASE_MESH:D011595 @@@agitation@@@ occurred which were not associated with discontinuations. ", "citations": {"NLM": "Bo QJ, Wang ZM, Li XB, Ma X, Wang CY, de Leon J. Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review. Psychiatry Res. 2016 Mar 30;237():257-63. PMID: 26822064", "BibTeX": "@article{26822064, title={Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review.}, author={Bo QJ and Wang ZM and Li XB and Ma X and Wang CY and de Leon J}, journal={Psychiatry Res}, volume={237}, pages={257-63}}"}}, {"_id": "29530699", "pmid": 29530699, "title": "Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study.", "journal": "World Neurosurg", "authors": ["Liu X", "Liu Y", "Gao J", "Feng M", "Bao X", "Deng K", "Yao Y", "Wang R"], "date": "2018-07-01T00:00:00Z", "doi": "10.1016/j.wneu.2018.02.188", "meta_date_publication": "2018 Jul", "meta_volume": "115", "meta_issue": "", "meta_pages": "94-98", "score": 50050.64, "text_hl": "As menstruation resumed and @<m>DISEASE_Galactorrhea</m> @DISEASE_MESH:D005687 @@@galactorrhea@@@ resolved, the @SPECIES_9606 @@@patient@@@ became pregnant and stopped using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ but continued taking @CHEMICAL_Bromocriptine @CHEMICAL_MESH:D001971 @@@bromocriptine@@@. ", "citations": {"NLM": "Liu X, Liu Y, Gao J, Feng M, Bao X, Deng K, Yao Y, Wang R. Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study. World Neurosurg. 2018 Jul;115():94-98. PMID: 29530699", "BibTeX": "@article{29530699, title={Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study.}, author={Liu X and Liu Y and Gao J and Feng M and Bao X and Deng K and Yao Y and Wang R}, journal={World Neurosurg}, volume={115}, pages={94-98}}"}}]}